Postmarketing Surveillance Helps Identify Vaccine Safety Issues
TUESDAY, July 28, 2020 -- A review of all safety-related labeling changes for FDA-approved vaccines during a 20-year period shows vaccines are largely safe, and many of the safety issues are identified through postmarketing surveillance, according to a study published online July 28 in the Annals of Internal Medicine.
Noam Tau, M.D., from Tel Aviv University in Israel, and colleagues conducted a retrospective cohort study to describe the prevalence and characteristics of postapproval, safety-related label changes on initial and subsequent labels of 57 U.S. Food and Drug Administration-approved vaccines between Jan. 1, 1996, and Dec. 31, 2015.
The researchers found that for 93 percent of the vaccines, initial approval of the vaccines was supported by randomized controlled trials, with a median cohort size of 4,161 participants. Fifty-eight postapproval, safety-related label modifications were identified in association with 25 vaccines (49 warnings and precautions, eight contraindications, and one safety-related withdrawal). Vaccines with and without postmarketing, safety-related label modifications had similar initial approval trial characteristics. Expansion of population restrictions was the most common safety issue triggering label modifications, followed by allergies (36 and 22 percent, respectively). Postmarketing surveillance was the most common source of safety data (48 percent).
"A large proportion of emerging safety issues were rapidly identified through current postmarketing surveillance programs, including the safety signal, which led to the withdrawal of a single vaccine," the authors write.
© 2021 HealthDay. All rights reserved.
Posted July 2020
Read this next
MONDAY, June 21, 2021 -- In a research letter published online June 16 in Circulation, seven cases are presented of patients hospitalized for acute myocarditis-like illness...
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 14 to 18, 2021. This roundup...
FRIDAY, June 18, 2021 -- COVID-19 vaccination coverage is low among pregnant women in the United States, according to research published in the June 18 issue of the U.S. Centers...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.